Jennifer Markarian

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

The New Jersey-licensed specialty pharmacy recalls magnesium sulfate products and halts all production operations.

Product sold online in Malaysia and Indonesia infringes on the company’s trademark.

A GBI Research report says the opioid market will be driven by development of new products and post-marketing studies designed to reduce abuse risk.

Group sales were down, but R&D progress points to future growth.

Two general chapters on elemental impurities? limits and procedures are to become official Feb. 1, 2013, with implementation proposed for May 1, 2014.

Rutgers engineers constructed a direct compaction line in collaboration with Janssen.

Eli Lilly expects overall revenue growth in the coming year.

The US Supreme Court accepted an appeal by the Federal Trade Commission of a decision that upheld an arrangement of payments by Solvay Pharmaceuticals to generic drug companies to postpone introduction of generic versions of its branded testosterone-replacement drug.